National Institute of Neurological Disorders and Stroke; Notice of Meeting, 18389-18390 [E9-9236]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 76 / Wednesday, April 22, 2009 / Notices
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703,
parsadaniana@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Aging and
Economics.
Date: June 17, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
National Institutes of Health, Gateway
Building, Room 2C/212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7703, ferrellrj@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel,
Mitochondrial Antioxidants and Aging.
Date: June 19, 2009.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
National Institutes of Health, Gateway
Building, Room 2C/212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703,
parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9276 Filed 4–21–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
dwashington3 on PROD1PC60 with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
VerDate Nov<24>2008
15:31 Apr 21, 2009
Jkt 217001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 28–29, 2009.
Open: May 28, 2009, 10:30 a.m. to 4:45
p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research; Other Administrative
and Program Developments; and an
Overview of the NINDS Intramural Program.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 28, 2009, 4:45 p.m. to 5:15
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ Reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 29, 2009, 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Associate Director for Extramural Research,
National Institute of Neurological, Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
18389
Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9225 Filed 4–21–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Clinical Trials Subcommittee.
Date: May 27–28, 2009.
Closed: May 27, 2009, 6 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Open: May 28, 2009, 8 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Deborah G Hirtz, MD,
Acting Director, Clinical Trials Cluster,
National Institute of Neurological Disorders
and Stroke, National Institute of Health, 6001
Executive Blvd., Suite 2212, Bethesda, MD
20892. (301) 496–5821. hirtz@ninds.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
E:\FR\FM\22APN1.SGM
22APN1
18390
Federal Register / Vol. 74, No. 76 / Wednesday, April 22, 2009 / Notices
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9236 Filed 4–21–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Office of Refugee Resettlement SingleSource Program Expansion
Supplement
dwashington3 on PROD1PC60 with NOTICES
AGENCY: Office of Refugee Resettlement,
Administration for Children and
Families, HHS.
Subject: Single-Source Program
Expansion Supplement.
ACTION: Notice to Award a Single-Source
Program Expansion Supplement to the
North Dakota Department of Human
Services (NDHS) under the North
Dakota Wilson-Fish Program.
CFDA#: 93.583.
Legislative Authority: The Refugee Act
of 1980 as amended, Wilson-Fish
Amendment, 8 U.S.C. 1522(e)(7);
section 412(e)(7)(A) of the Immigration
and Nationality Act.
Amount of Award: $181,184
supplement for current year.
Project Period: 09/30/2005–09/29/
2010.
Justification for the Exception to
Competition: The Wilson-Fish program
is an alternative to the traditional Stateadministered refugee assistance program
for providing integrated assistance and
services to refugees, asylees, Amerasian
Immigrants, Cuban and Haitian
Entrants, Trafficking Victims and Iraqi/
Afghani SIV’s. North Dakota is one of 12
sites that has chosen this alternative
approach.
The supplemental funds will allow
the grantee, NDHS, to provide refugee
cash assistance through the end of this
fiscal year to eligible refugees (and
others eligible for refugee benefits)
VerDate Nov<24>2008
15:31 Apr 21, 2009
Jkt 217001
under the North Dakota Wilson-Fish
Program.
The primary reason for the grantee’s
supplemental request is a higher
number of arrivals than anticipated
when the grantee’s budget was
submitted and approved last year. The
Refugee Act of 1980 mandates that the
Office of Refugee Resettlement (ORR)
reimburse States and Wilson-Fish
projects for the costs of cash and
medical assistance for newly arriving
refugees. Since 1991, ORR has
reimbursed States and Wilson-Fish
agencies for providing cash and medical
assistance to eligible individuals during
their first eight months in the United
States.
Hence, the supplement is consistent
with the purposes of the Wilson-Fish
Program, the Refugee Act of 1980, and
ORR policy.
FOR FURTHER INFORMATION CONTACT: Carl
Rubenstein, Wilson-Fish Program
Manager, Office of Refugee
Resettlement, Aerospace Building, 8th
Floor West, 901 D Street, SW.,
Washington, DC 20447. Telephone:
202–205–5933.
Dated: April 6, 2009.
David H. Siegel,
Acting Director, Office of Refugee
Resettlement.
[FR Doc. E9–9269 Filed 4–21–09; 8:45 am]
BILLING CODE ;P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Refugee Resettlement
Vermont Refugee Resettlement
Program
AGENCY: Office of Refugee Resettlement,
Administration for Children and
Families, HHS.
ACTION: Single-Source Program
Expansion Supplement; Notice to
Award a Single-Source Program
Expansion Supplement to the U.S.
Committee for Refugees and
Immigrants—Vermont Refugee
Resettlement Program (USCRI–VRRP)
under the Vermont Wilson-Fish
Program.
CFDA#: 93.583
Legislative Authority: The Refugee Act
of 1980 as amended, Wilson-Fish
Amendment, 8 U.S.C. 1522(e)(7);
section 412(e)(7)(A) of the Immigration
and Nationality Act.
Amount of Award: $414,041
supplement for current year.
Project Period: 09/30/2005–09/29/
2010.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Justification for the Exception to
Competition: The Wilson-Fish program
is an alternative to the traditional Stateadministered refugee assistance program
for providing integrated assistance and
services to refugees, asylees, Amerasian
Immigrants, Cuban and Haitian
Entrants, Trafficking Victims and Iraqi/
Afghani SIV’s. Vermont is one of 12
sites that has chosen this alternative
approach.
The supplemental funds will allow
the grantee, USCRI–VRRP, to provide
refugee cash assistance through the end
of this fiscal year to eligible refugees
(and others eligible for refugee benefits)
under the Vermont Wilson-Fish
Program.
The primary reason for the grantee’s
supplemental request is a higher
number of arrivals than anticipated
when the grantee’s budget was
submitted and approved last year. The
Refugee Act of 1980 mandates that the
Office of Refugee Resettlement (ORR)
reimburse States and Wilson-Fish
projects for the costs of cash and
medical assistance for newly arriving
refugees. Since 1991, ORR has
reimbursed States and Wilson-Fish
agencies for providing cash and medical
assistance to eligible individuals during
their first eight months in the United
States.
Hence, the supplement is consistent
with the purposes of the Wilson-Fish
Program, the Refugee Act of 1980, and
ORR policy.
FOR FURTHER INFORMATION CONTACT: Carl
Rubenstein, Wilson-Fish Program
Manager, Office of Refugee
Resettlement, Aerospace Building, 8th
Floor West, 901 D Street, SW.,
Washington, DC 20447. Telephone:
202–205–5933.
Dated: April 6, 2009.
David H. Siegel,
Acting Director, Office of Refugee
Resettlement.
[FR Doc. E9–9282 Filed 4–21–09; 8:45 am]
BILLING CODE P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Form I–824, Extension of an
Existing Information Collection;
Comment Request
ACTION: 60-Day Notice of Information
Collection Under Review: Form I–824,
Application for Action on an Approved
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 74, Number 76 (Wednesday, April 22, 2009)]
[Notices]
[Pages 18389-18390]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9236]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Neurological Disorders and Stroke Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Clinical Trials Subcommittee.
Date: May 27-28, 2009.
Closed: May 27, 2009, 6 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Open: May 28, 2009, 8 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Deborah G Hirtz, MD, Acting Director, Clinical
Trials Cluster, National Institute of Neurological Disorders and
Stroke, National Institute of Health, 6001 Executive Blvd., Suite
2212, Bethesda, MD 20892. (301) 496-5821. hirtz@ninds.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on
[[Page 18390]]
campus. Visitors will be asked to show one form of identification
(for example, a government-issued photo ID, driver's license, or
passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: April 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-9236 Filed 4-21-09; 8:45 am]
BILLING CODE 4140-01-P
